NEURO2026

*Akimasa koyama Koyama^1,4, Tomoyuki Fujiyama^1,4, Staci Kim^1,4, Tomohiro Kitazono^1,4, Jing Ma^1,4, Miyanishi Kazuya^1,4, Satomi Kanno^1,4, Miyo Kakizaki^1,4, Seiya Mizuno², Satoru Takahashi², Hiromasa Funato^1,3,4, Masashi Yanagisawa^1,4 (1. University of Tsukuba International Institute for Integrative Sleep Medicine (WPI-IIIS), 2. Laboratory Animal Resource Center, University of Tsukuba , 3. Department of Anatomy, Toho University, 4. Tsukuba Institute fur Advanced Research (TIAR))

*Ayaka Fujimaki¹, Natalia Pokaleva², Alexa Zarjetskiy², Masatoshi Inden¹, Masashi Tabuchi² (1. Grad Sch Pharm Sci, Gifu Pharm Univ, Gifu, Japan, 2. Sch Med, Case Western Reserve Univ, Cleveland, OH, USA)

*Ren Sato¹, Hiroaki Nishimura¹, Sho T Yamaguchi¹, Yasutaka Mukai¹, Sarah Dagher², Shimpei Ishiyama³, Yoshifumi Yamaguchi⁴, Hiroaki Norimoto¹ (1. Grad Sch Sci, Nagoya Univ, Aichi, Japan, 2. MPI for Metabolism Research, Köln, Germany, 3. Dept Neuropeptide Research, ZI, Mannheim, Germany, 4. Inst Low Tem Sci, Hokkaido Univ, Sapporo, Japan)

*Tomohiro Tokutake¹, Jun Yokose¹, Yusuke Yano¹, Yuki Shigetsura², Shin-Ichi Muramatsu³, Atsumi Nitta¹ (1. Department of Pharmaceutical Therapy & Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, Japan., 2. Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan., 3. Division of Neurological Gene Therapy, Open Innovation Center, Jichi Medical University, Shimotsuke, Japan.)